Cash From Financing Activities - Vita 34 AG (XETRA:V3V) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 5.15 EUR 6.4%

Updated:

Vita 34 AG
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Vita 34 AG
Cash from Financing Activities Peer Comparison

F

FME

F

FRE

E

1846

SYAB

Company		Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Vita 34 AG XETRA:V3V	Cash from Financing Activities -€9.2m	CAGR 3-Years -61%	CAGR 5-Years -27%	CAGR 10-Years -21%
F	Fresenius Medical Care AG & Co KGaA XETRA:FME	Cash from Financing Activities -€1.9B	CAGR 3-Years 11%	CAGR 5-Years -22%	CAGR 10-Years -12%
F	Fresenius SE & Co KGaA XETRA:FRE	Cash from Financing Activities -€1.4B	CAGR 3-Years 24%	CAGR 5-Years -2%	CAGR 10-Years N/A
E	Euroeyes International Eye Clinic Ltd HKEX:1846	Cash from Financing Activities -HK$102.2m	CAGR 3-Years 4%	CAGR 5-Years -18%	CAGR 10-Years N/A
	Synlab AG XETRA:SYAB	Cash from Financing Activities -€825.2m	CAGR 3-Years -47%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Sep 30, 2023, Vita 34 AG's Cash from Financing Activities amounts to -9.2m EUR.

Over the last year, the Cash from Financing Activities growth was -26%. The average annual Cash from Financing Activities growth rates for Vita 34 AG have been -61% over the past three years , -27% over the past five years , and -21% over the past ten years .

Join more than 131,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.